TargetCancer Foundation
  • About
    • About TCF
    • Our Impact
    • Our Team
    • Partners & Collaborators
    • News & Updates
    • Frequently Asked Questions
    • Financials
  • Learn
    • Rare Cancer Resources
    • What is a Rare Cancer?
    • Initial Steps After a Rare Cancer Diagnosis
    • Biomarker Testing in Rare Cancers
    • Clinical Trials
    • Video Library
    • Glossary
  • Research
    • Our Initiatives
    • TCF-001 TRACK
    • Our Funded Research
    • Scientific Meetings
    • Publications
  • Events
    • TCF Events
    • TargetCancer Foundation Gala
    • A Night to Strike Out Rare Cancer
    • Webinars
    • Scientific Meetings
    • Boston Marathon
    • Rare Cancer Day
  • Get Involved
    • Ways to Get Involved
    • Donate
    • Plan a Community Fundraiser
    • Join Team TCF
    • Volunteer
  • Blog
  • Contact
Genomic Testing in Rare Cancers: A Critical Step

Genomic Testing in Rare Cancers: A Critical Step

by TargetCancer | Mar 1, 2024

YouTube Video VVVwdUloZXZaVm5GYlR5U1NxMTJnNlhRLkdvU0ZFSTN1aVVn Using cholangiocarcinoma as an example, this video illustrates the importance of genomic testing in rare cancers. Credit: Foundation Medicine, Inc.
Using cholangiocarcinoma as an example, this video illustrates the importance of genomic testing in rare cancers. Credit: Foundation Medicine, Inc.
Women In Oncology: TRACK Clinical Trial

Women In Oncology: TRACK Clinical Trial

by TargetCancer | Mar 1, 2024

YouTube Video VVVwdUloZXZaVm5GYlR5U1NxMTJnNlhRLk5la015TnByUVF3 An hour-long Lunch & Learn panel event with five leaders of TargetCancer Foundation's TCF-001 TRACK study, held on May 19, 2022. These five inspiring and accomplished leaders discuss the challenges that come from being women in a traditionally male dominated field. They also discuss the strategies they have learned, including the value of a mentor, to overcome those challenges to achieve success.
An hour-long Lunch & Learn panel event with five leaders of TargetCancer Foundation’s TCF-001 TRACK study, held on May 19, 2022. These five inspiring and accomplished leaders discuss the challenges that come from being women in a traditionally male dominated...
2022 TargetCancer Foundation Gala Keynote Speaker Allen Chankowsky

2022 TargetCancer Foundation Gala Keynote Speaker Allen Chankowsky

by TargetCancer | Mar 1, 2024

YouTube Video VVVwdUloZXZaVm5GYlR5U1NxMTJnNlhRLk5EUm9YaU1tdWxn
TargetCancer Foundation Think Tank on Advancing Precision Medicine in Rare Cancers

TargetCancer Foundation Think Tank on Advancing Precision Medicine in Rare Cancers

by TargetCancer | Mar 1, 2024

YouTube Video VVVwdUloZXZaVm5GYlR5U1NxMTJnNlhRLkNUdWJzWTl6TVg0 Molecular Tumor Board at the TargetCancer Foundation Think Tank on Advancing Precision Medicine in Rare Cancers. Recorded on September 21, 2022, Boston MA
Molecular Tumor Board at the TargetCancer Foundation Think Tank on Advancing Precision Medicine in Rare Cancers. Recorded on September 21, 2022, Boston MA
It’s All in the Genes, The Differing Roles of Genomic and Genetic Testing in Precision Medicine

It’s All in the Genes, The Differing Roles of Genomic and Genetic Testing in Precision Medicine

by TargetCancer | Mar 1, 2024

YouTube Video VVVwdUloZXZaVm5GYlR5U1NxMTJnNlhRLk5TTXdoS3lwbDJN A TargetCancer Foundation Lunch and Learn webinar held on June 15, 2023, featuring: <br /><br />Julia Elvin, MD, PhD, Senior Vice President, Pathology & Diagnostic Medicine at Foundation Medicine<br /><br />Catherine Skefos, MA, MS, CGC, Genetic Counselor at MD Anderson Cancer Center<br /><br />Moderated by Mary Pat Lancelotta, Senior Vice President, BioPharma at Adaptive Biotechnologies Corp.
A TargetCancer Foundation Lunch and Learn webinar held on June 15, 2023, featuring: Julia Elvin, MD, PhD, Senior Vice President, Pathology & Diagnostic Medicine at Foundation Medicine Catherine Skefos, MA, MS, CGC, Genetic Counselor at MD Anderson Cancer Center...
« Older Entries
Next Entries »

Recent Posts

  • Translating Loss into Discovery: Paul’s Legacy
  • A Promise Fulfilled: 15 Years After Paul Poth’s Vision, a New Era in Cholangiocarcinoma Research Begins
  • The Power of Advocacy: Collective Strength Through the Rare Cancer Patient Voice Webinar
  • Good luck Team TCF25!
  • TCF’s Spring Marathon of Events

Recent Comments

No comments to show.

[email protected]
(617) 765-4881

Join our Mailing List

Privacy(Required)
Donate
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
Gold Transparency 2023 Candid Charity Navigator Four-Star

TargetCancer Foundation
TargetCancer Foundation is a recognized 501(c)(3) charity, Tax ID 26-4510094.

  • About TCF
    • Our Impact
    • Our Team
    • Partners & Collaborators
    • News & Updates
    • Frequently Asked Questions
    • Financials
  • OnTarget Blog
  • Contact
  • Learn
    • What is a Rare Cancer?
    • Initial Steps After a Rare Cancer Diagnosis
    • Biomarker Testing in Rare Cancers
    • Clinical Trials
    • Video Library
    • Glossary
  • Research
    • TCF-001 TRACK
    • Our Funded Research
    • Scientific Meetings
    • Webinars
    • Publications
  • Events
    • TargetCancer Foundation Gala
    • Webinars
    • A Night to Strike Out Rare Cancer
    • Scientific Meetings
    • Boston Marathon
    • Rare Cancer Day
  • Get Involved
    • Donate
    • Plan a Community Fundraiser
    • Join Team TCF
    • Volunteer

All content and images copyright © 2025 TargetCancer Foundation. All rights reserved. | Privacy Policy